Phenotypes and personalized medicine in the acute respiratory distress syndrome

[1]  A. Mebazaa,et al.  Designing an ARDS trial for 2020 and beyond: focus on enrichment strategies , 2020, Intensive Care Medicine.

[2]  M. Matthay,et al.  Corticosteroids, COVID-19 pneumonia and acute respiratory distress syndrome. , 2020, The Journal of clinical investigation.

[3]  Arthur S Slutsky,et al.  Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. , 2020, JAMA.

[4]  M. Shankar-Hari,et al.  Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study , 2020, The Lancet Respiratory Medicine.

[5]  K. Jones,et al.  Dose-Dependent Pulmonary Toxicity of Aerosolized Vitamin E Acetate. , 2020, American journal of respiratory cell and molecular biology.

[6]  B. Souweine,et al.  Early Changes Over Time in the Radiographic Assessment of Lung Edema Score Are Associated With Survival in ARDS , 2020, Chest.

[7]  Pratik Sinha,et al.  Is a "Cytokine Storm" Relevant to COVID-19? , 2020, JAMA internal medicine.

[8]  Jennifer L. Bell,et al.  Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.

[9]  L. Bos,et al.  The perils of premature phenotyping in COVID-19: a call for caution , 2020, European Respiratory Journal.

[10]  L. Dodd,et al.  Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.

[11]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[12]  J. M. Crawford,et al.  Targeting potential drivers of COVID-19: Neutrophil extracellular traps , 2020, The Journal of experimental medicine.

[13]  N. Yehya,et al.  Predicting Mortality in Children With Pediatric Acute Respiratory Distress Syndrome: A Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Study , 2020, Critical care medicine.

[14]  E. Seeley,et al.  Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis , 2020, Intensive Care Medicine.

[15]  H. Pape,et al.  Mortality of Adult Respiratory Distress Syndrome in Trauma Patients: A Systematic Review over a Period of Four Decades , 2020, World Journal of Surgery.

[16]  A. Fowler,et al.  Vitamin C for Sepsis and Acute Respiratory Failure-Reply. , 2020, JAMA.

[17]  M. Hall.  National Heart, Lung, and Blood Institute , 2020, The Grants Register 2021.

[18]  J. González-Martín,et al.  Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. , 2020, The Lancet. Respiratory medicine.

[19]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[20]  F. Hayden,et al.  Critical care management of adults with community-acquired severe respiratory viral infection , 2020, Intensive Care Medicine.

[21]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[22]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[23]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[24]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[25]  K. Delucchi,et al.  Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. , 2020, The Lancet. Respiratory medicine.

[26]  S. Wenzel,et al.  High-Dose Vitamin D3 for Critically Ill Vitamin D-Deficient Patients. , 2019, The New England journal of medicine.

[27]  P. Benos,et al.  The evolution of radiographic edema in ARDS and its association with clinical outcomes: A prospective cohort study in adult patients. , 2019, Journal of critical care.

[28]  Brian A. King,et al.  Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Preliminary Report. , 2020, The New England journal of medicine.

[29]  J. Derisi,et al.  Detection of Pneumonia Pathogens from Plasma Cell-Free DNA. , 2020, American journal of respiratory and critical care medicine.

[30]  R. Hyzy,et al.  Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients. , 2019, The New England journal of medicine.

[31]  Christina D Diaz,et al.  Pulmonary Illness Related to E-Cigarette Use. , 2019, The New England journal of medicine.

[32]  Adam T Froemming,et al.  Pathology of Vaping-Associated Lung Injury. , 2019, The New England journal of medicine.

[33]  G. Martin,et al.  Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. , 2019, JAMA.

[34]  M. Fine,et al.  Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America , 2019, American journal of respiratory and critical care medicine.

[35]  B. Souweine,et al.  Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial. , 2019, The Lancet. Respiratory medicine.

[36]  D. Angus,et al.  Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. Reply. , 2019, The New England journal of medicine.

[37]  C. Hillyer,et al.  Ten years of TRALI mitigation: measuring our progress , 2019, Transfusion.

[38]  S. R. Lewis,et al.  Pharmacological agents for adults with acute respiratory distress syndrome. , 2019, The Cochrane database of systematic reviews.

[39]  T. van der Poll,et al.  Understanding Heterogeneity in Biological Phenotypes of ARDS by Leukocyte Expression Profiles. , 2019, American journal of respiratory and critical care medicine.

[40]  David T. Huang,et al.  Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. , 2019, The New England journal of medicine.

[41]  David T. Huang,et al.  Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. , 2019, The New England journal of medicine.

[42]  J. Knight,et al.  Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial , 2019, American journal of respiratory and critical care medicine.

[43]  L. Papazian,et al.  Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome , 2019, Annals of Intensive Care.

[44]  D. Cook,et al.  Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure–Guided Strategy vs an Empirical High PEEP-FIO2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial , 2019, JAMA.

[45]  J. Laffey,et al.  Declining Mortality in Patients With Acute Respiratory Distress Syndrome: An Analysis of the Acute Respiratory Distress Syndrome Network Trials , 2019, Critical care medicine.

[46]  Epidemiology Investigators,et al.  Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study , 2019 .

[47]  J. Beitler.  Bedside respiratory physiology to detect risk of lung injury in acute respiratory distress syndrome , 2019, Current opinion in critical care.

[48]  C. Calfee,et al.  Phenotypes in acute respiratory distress syndrome: moving towards precision medicine , 2019, Current opinion in critical care.

[49]  N. Yehya,et al.  Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. , 2019, The Lancet. Respiratory medicine.

[50]  J. Beitler,et al.  Physiologic Analysis and Clinical Performance of the Ventilatory Ratio in Acute Respiratory Distress Syndrome , 2019, American journal of respiratory and critical care medicine.

[51]  Michael A. Matthay,et al.  Acute respiratory distress syndrome , 1996, Nature reviews. Disease primers.

[52]  Byuh Ree Kim,et al.  소아 급성호흡곤란증후군에서 Pediatric Acute Lung Injury Consensus Conference 정의의 임상적 적용 , 2019 .

[53]  Sivan Bercovici,et al.  Liquid biopsy for infectious diseases: Sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease , 2018, bioRxiv.

[54]  J. Major,et al.  National incidence rates for Acute Respiratory Distress Syndrome (ARDS) and ARDS cause‐specific factors in the United States (2006–2014)☆ , 2018, Journal of critical care.

[55]  J. Laffey,et al.  Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. , 2018, The Lancet. Respiratory medicine.

[56]  Tatsuki Koyama,et al.  Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS , 2018, Thorax.

[57]  Katherine S. Pollard,et al.  Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults , 2018, Proceedings of the National Academy of Sciences.

[58]  Purvesh Khatri,et al.  Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters , 2018, Critical care medicine.

[59]  Jeanine Wiener-Kronish,et al.  The Acute Respiratory Distress Syndrome Network , 2018 .

[60]  J. Bastarache,et al.  Novel Method for Noninvasive Sampling of the Distal Airspace in Acute Respiratory Distress Syndrome , 2017, American journal of respiratory and critical care medicine.

[61]  W. Al-Nakib,et al.  Metagenomic analysis of viral diversity in respiratory samples from patients with respiratory tract infections in Kuwait , 2017, Journal of medical virology.

[62]  M. Wurfel,et al.  Peripheral and Alveolar Cell Transcriptional Programs Are Distinct in Acute Respiratory Distress Syndrome , 2017, American journal of respiratory and critical care medicine.

[63]  S. Opal,et al.  Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration* , 2018, Critical care medicine.

[64]  Peter Nürnberg,et al.  Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. , 2017, The Lancet. Respiratory medicine.

[65]  Arthur S Slutsky,et al.  Applying Precision Medicine to Trial Design Using Physiology. Extracorporeal CO2 Removal for Acute Respiratory Distress Syndrome , 2017, American journal of respiratory and critical care medicine.

[66]  J. Schrenzel,et al.  Detection of Bacterial Pathogens from Broncho-Alveolar Lavage by Next-Generation Sequencing , 2017, International journal of molecular sciences.

[67]  R. Kacmarek,et al.  Transpulmonary Pressure Describes Lung Morphology During Decremental Positive End-Expiratory Pressure Trials in Obesity* , 2017, Critical care medicine.

[68]  D. Talmor,et al.  Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome* , 2017, Critical care medicine.

[69]  T. van der Poll,et al.  Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis , 2017, Thorax.

[70]  Cheng-Ta Yang,et al.  Coinfection and Mortality in Pneumonia-Related Acute Respiratory Distress Syndrome Patients with Bronchoalveolar Lavage: A Prospective Observational Study , 2017, Shock.

[71]  M. Matthay,et al.  Protein biomarkers associated with primary graft dysfunction following lung transplantation. , 2017, American journal of physiology. Lung cellular and molecular physiology.

[72]  Zhiguo Zhao,et al.  Clinical Predictors of Hospital Mortality Differ Between Direct and Indirect ARDS , 2017, Chest.

[73]  K. Famous,et al.  Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy , 2016, American journal of respiratory and critical care medicine.

[74]  P. Tuinman,et al.  Prevention or Treatment of Ards With Aspirin: A Review of Preclinical Models and Meta-Analysis of Clinical Studies , 2017, Shock.

[75]  M. Matthay,et al.  Negative-Pressure Pulmonary Edema. , 2016, Chest.

[76]  L. Gattinoni,et al.  Ventilator-related causes of lung injury: the mechanical power , 2016, Intensive Care Medicine.

[77]  Peggy Cruse,et al.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[78]  D. Talmor,et al.  Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial. , 2016, Journal of the American Medical Association (JAMA).

[79]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[80]  Anna Rautanen,et al.  Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study , 2016, The Lancet. Respiratory medicine.

[81]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[82]  R. Hyzy,et al.  The role of human metapneumovirus in the critically ill adult patient. , 2016, Journal of critical care.

[83]  A. Conway Morris,et al.  Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  D. Talmor,et al.  Volume Delivered During Recruitment Maneuver Predicts Lung Stress in Acute Respiratory Distress Syndrome* , 2016, Critical Care Medicine.

[85]  G. Rubenfeld,et al.  Physiologic Responsiveness Should Guide Entry into Randomized Controlled Trials. , 2015, American journal of respiratory and critical care medicine.

[86]  G. Rohde,et al.  Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients , 2015, BMC Pulmonary Medicine.

[87]  L. Brochard,et al.  High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. , 2015, The New England journal of medicine.

[88]  J. Zimmerman,et al.  Pediatric Acute Respiratory Distress Syndrome: Definition, Incidence, and Epidemiology Proceedings From the Pediatric Acute Lung Injury Consensus Conference , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[89]  M. Dahmer,et al.  Comorbidities and Assessment of Severity of Pediatric Acute Respiratory Distress Syndrome: Proceedings From the Pediatric Acute Lung Injury Consensus Conference , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[90]  M. Dahmer,et al.  Pathobiology of acute respiratory distress syndrome. , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[91]  I. Cheifetz,et al.  Ventilatory Support in Children With Pediatric Acute Respiratory Distress Syndrome: Proceedings From the Pediatric Acute Lung Injury Consensus Conference , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[92]  D. Talmor,et al.  Estimating Dead-Space Fraction for Secondary Analyses of Acute Respiratory Distress Syndrome Clinical Trials , 2015, Critical care medicine.

[93]  Arthur S Slutsky,et al.  Driving pressure and survival in the acute respiratory distress syndrome. , 2015, The New England journal of medicine.

[94]  G. Bernard,et al.  Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. , 2014, Chest.

[95]  G. Perkins,et al.  Simvastatin in the acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[96]  Kevin Delucchi,et al.  Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. , 2014, The Lancet. Respiratory medicine.

[97]  Arthur S Slutsky,et al.  Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. , 2014, American journal of respiratory and critical care medicine.

[98]  R. Gallop,et al.  Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma. , 2014, Annals of the American Thoracic Society.

[99]  I. Douglas,et al.  Rosuvastatin for sepsis-associated acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[100]  H. Rohde,et al.  Rapid Metagenomic Diagnostics for Suspected Outbreak of Severe Pneumonia , 2014, Emerging infectious diseases.

[101]  T. Ala-Kokko,et al.  Lower Respiratory Tract Virus Findings in Mechanically Ventilated Patients With Severe Community-Acquired Pneumonia , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[102]  K. Baumstarck,et al.  Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation , 2014, Intensive Care Medicine.

[103]  A. Randolph,et al.  Mechanical Ventilation Strategies in Children With Acute Lung Injury: A Survey on Stated Practice Pattern* , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[104]  Benjamin A Goldstein,et al.  Early Acute Lung Injury: Criteria for Identifying Lung Injury Prior to the Need for Positive Pressure Ventilation* , 2013, Critical care medicine.

[105]  S. Jaber,et al.  Prone positioning in severe acute respiratory distress syndrome. , 2013, The New England journal of medicine.

[106]  L. Blanch,et al.  A universal definition of ARDS: the PaO2/FiO2 ratio under a standard ventilatory setting—a prospective, multicenter validation study , 2013, Intensive Care Medicine.

[107]  Richard Beale,et al.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material , 2012, Intensive Care Medicine.

[108]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[109]  R. Weiskopf,et al.  Transfusion-related acute lung injury: incidence and risk factors. , 2012, Blood.

[110]  Anna Wetterbom,et al.  Characterization of the Viral Microbiome in Patients with Severe Lower Respiratory Tract Infections, Using Metagenomic Sequencing , 2012, PloS one.

[111]  I. Douglas,et al.  Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. , 2011, American journal of respiratory and critical care medicine.

[112]  A. Randolph,et al.  Acute lung injury in children: Therapeutic practice and feasibility of international clinical trials* , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[113]  王林,et al.  Acute Respiratory Distress Syndrome Network , 2010 .

[114]  A. Loundou,et al.  Neuromuscular blockers in early acute respiratory distress syndrome. , 2010, The New England journal of medicine.

[115]  F. Chen,et al.  Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. , 2010, Chest.

[116]  M. Sebbane,et al.  Lung morphology predicts response to recruitment maneuver in patients with acute respiratory distress syndrome , 2010, Critical care medicine.

[117]  F. Chen,et al.  The influence of infection sites on development and mortality of ARDS , 2010, Intensive Care Medicine.

[118]  M. Curley,et al.  Defining acute lung disease in children with the oxygenation saturation index* , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[119]  Lung.  Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome , 2009 .

[120]  E. Ruokonen,et al.  Acute respiratory failure in intensive care units. FINNALI: a prospective cohort study , 2009, Intensive Care Medicine.

[121]  G. Martin,et al.  Recent trends in acute lung injury mortality: 1996–2005* , 2009, Critical care medicine.

[122]  M. Gould,et al.  Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure. , 2009, Chest.

[123]  M. Siegel,et al.  Randomized clinical trial of activated protein C for the treatment of acute lung injury. , 2008, American journal of respiratory and critical care medicine.

[124]  Massimo Cressoni,et al.  Lung stress and strain during mechanical ventilation for acute respiratory distress syndrome. , 2008, American journal of respiratory and critical care medicine.

[125]  S Lundin,et al.  Bronchoscopic suctioning may cause lung collapse: a lung model and clinical evaluation , 2008, Acta anaesthesiologica Scandinavica.

[126]  Jesús Blanco,et al.  An early PEEP/FIO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome. , 2007, American journal of respiratory and critical care medicine.

[127]  Gordon R Bernard,et al.  Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.

[128]  D. Talmor,et al.  Esophageal and transpulmonary pressures in acute respiratory failure* , 2006, Critical care medicine.

[129]  G. Perkins,et al.  Role of nonbronchoscopic lavage for investigating alveolar inflammation and permeability in acute respiratory distress syndrome , 2006, Critical care medicine.

[130]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[131]  Marek Ancukiewicz,et al.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. , 2009, The New England journal of medicine.

[132]  J. Pittet,et al.  Prognostic value of the pulmonary dead-space fraction during the first 6 days of acute respiratory distress syndrome. , 2004, Respiratory care.

[133]  W. Seeger,et al.  Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. , 2004, The New England journal of medicine.

[134]  R. Sue,et al.  Hydrostatic mechanisms may contribute to the pathogenesis of human re-expansion pulmonary edema , 2004, Intensive Care Medicine.

[135]  Robert W. Taylor,et al.  Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. , 2004, JAMA.

[136]  L. Papazian,et al.  Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome* , 2004, Critical care medicine.

[137]  J. Pittet,et al.  Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. , 2002, The New England journal of medicine.

[138]  D. Schoenfeld,et al.  Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.

[139]  N. Goldsack,et al.  Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. , 2000, American journal of respiratory and critical care medicine.

[140]  L. Puybasset,et al.  Regional distribution of gas and tissue in acute respiratory distress syndrome. III. Consequences for the effects of positive end-expiratory pressure , 2000, Intensive Care Medicine.

[141]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[142]  D. Morabito,et al.  Initial severity of metabolic acidosis predicts the development of acute lung injury in severely traumatized patients , 2000, Critical care medicine.

[143]  A. Clément,et al.  Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. , 2000 .

[144]  C. Carvalho,et al.  Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. , 1998, The New England journal of medicine.

[145]  M. Matthay,et al.  Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. , 1997, American journal of respiratory and critical care medicine.